FDA approves new HIV drug from J&J

The FDA approved Johnson & Johnson's HIV drug Prezista for treating patients who do not respond to treatment with other antiretroviral medicines. Prezista is in the class of protease inhibitor drugs, which work by blocking protease, a protein HIV needs to copy itself.

View Full Article in:

Newsday (Long Island, N.Y.) (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA